MX2010004772A - Recubrimiento mejorado de tableta. - Google Patents

Recubrimiento mejorado de tableta.

Info

Publication number
MX2010004772A
MX2010004772A MX2010004772A MX2010004772A MX2010004772A MX 2010004772 A MX2010004772 A MX 2010004772A MX 2010004772 A MX2010004772 A MX 2010004772A MX 2010004772 A MX2010004772 A MX 2010004772A MX 2010004772 A MX2010004772 A MX 2010004772A
Authority
MX
Mexico
Prior art keywords
tablet coating
improved tablet
provides
present
tablet
Prior art date
Application number
MX2010004772A
Other languages
English (en)
Spanish (es)
Inventor
David John Willoughby
Original Assignee
Sanofi Aventis Healthcare Pty
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40535662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010004772(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AU2007906008A external-priority patent/AU2007906008A0/en
Application filed by Sanofi Aventis Healthcare Pty filed Critical Sanofi Aventis Healthcare Pty
Publication of MX2010004772A publication Critical patent/MX2010004772A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2010004772A 2007-11-01 2008-10-30 Recubrimiento mejorado de tableta. MX2010004772A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2007906008A AU2007906008A0 (en) 2007-11-01 Improved tablet coating
PCT/AU2008/001596 WO2009055846A1 (en) 2007-11-01 2008-10-30 Improved tablet coating

Publications (1)

Publication Number Publication Date
MX2010004772A true MX2010004772A (es) 2010-06-25

Family

ID=40535662

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004772A MX2010004772A (es) 2007-11-01 2008-10-30 Recubrimiento mejorado de tableta.

Country Status (18)

Country Link
US (1) US20100266687A1 (enExample)
EP (1) EP2217218A4 (enExample)
JP (1) JP2011502132A (enExample)
KR (1) KR20100098612A (enExample)
CN (1) CN101842087A (enExample)
AR (1) AR069158A1 (enExample)
AU (1) AU2008318270A1 (enExample)
CA (1) CA2704102A1 (enExample)
CL (1) CL2008003230A1 (enExample)
IL (1) IL205200A0 (enExample)
MX (1) MX2010004772A (enExample)
NZ (1) NZ584764A (enExample)
PA (1) PA8802901A1 (enExample)
PE (1) PE20091160A1 (enExample)
RU (1) RU2010122062A (enExample)
TW (1) TW200927198A (enExample)
UY (1) UY31452A1 (enExample)
WO (1) WO2009055846A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0912487D0 (en) * 2009-07-17 2009-08-26 Norgine Bv Improvements in and relating to colon cleansing compositions
DE202010010312U1 (de) * 2009-07-17 2010-11-04 Norgine B.V. Verbesserungen bei und bezüglich Kolonreinigungs-Zusammensetzungen
EP2675437B1 (en) * 2011-02-14 2018-01-24 The Procter and Gamble Company Filmcoated solid dosage forms comprising honey in the coating
WO2013172297A1 (ja) * 2012-05-14 2013-11-21 塩野義製薬株式会社 ６，７－不飽和－７－カルバモイルモルヒナン誘導体含有製剤
US20140099426A1 (en) * 2012-10-10 2014-04-10 Pharmavite Llc Natural coating formulas and composition for coating tablets
BR112015030617B1 (pt) * 2013-06-17 2020-12-22 Nippon Soda Co., Ltd formulação sólida
JP6196730B2 (ja) * 2014-03-31 2017-09-13 富山化学工業株式会社 セファロスポリンエステルを含む粒状固形製剤およびその製造方法
WO2018143423A1 (ja) 2017-02-03 2018-08-09 株式会社東洋新薬 固形製剤
CN110157516B (zh) * 2019-06-27 2021-11-23 合肥工业大学 纳米二氧化钛/黑磷纳米片复合润滑剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0527153T3 (da) * 1990-04-04 1996-11-25 Berwind Pharma Service Vandige filmovertræk af maltodextrin og cellulosepolymerer
US5098715A (en) * 1990-12-20 1992-03-24 Burroughs Wellcome Co. Flavored film-coated tablet
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
ATE273084T1 (de) * 1997-01-06 2004-08-15 Bpsi Holdings Inc Filmbeschichtungen und filmbeschichtungszusammensetzungen auf der basis von dextrin
US6660302B1 (en) * 2000-09-06 2003-12-09 Chr. Hansen, Inc. Dry-powder film coating composition and method of preparation
WO2002062393A2 (en) * 2001-02-02 2002-08-15 Metagenics, Inc. Coating for orally administered compositions
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US6656493B2 (en) * 2001-07-30 2003-12-02 Wm. Wrigley Jr. Company Edible film formulations containing maltodextrin
US20030026826A1 (en) * 2001-07-31 2003-02-06 Cherukuri Subraman Rao Sugar-free chewy products and protein-based chewy products and methods for making the same
ATE388693T1 (de) * 2002-04-04 2008-03-15 Pfizer Prod Inc Wohlschmeckende kautablette
ES2312632T5 (es) * 2002-09-24 2017-02-22 Gumlink A/S Goma de mascar de humedad baja
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose

Also Published As

Publication number Publication date
UY31452A1 (es) 2009-03-31
IL205200A0 (en) 2010-12-30
CN101842087A (zh) 2010-09-22
WO2009055846A1 (en) 2009-05-07
EP2217218A1 (en) 2010-08-18
US20100266687A1 (en) 2010-10-21
CA2704102A1 (en) 2009-05-07
TW200927198A (en) 2009-07-01
PA8802901A1 (es) 2009-07-23
EP2217218A4 (en) 2013-01-09
RU2010122062A (ru) 2011-12-10
JP2011502132A (ja) 2011-01-20
KR20100098612A (ko) 2010-09-08
AR069158A1 (es) 2009-12-30
AU2008318270A1 (en) 2009-05-07
NZ584764A (en) 2012-04-27
PE20091160A1 (es) 2009-08-06
CL2008003230A1 (es) 2009-11-27

Similar Documents

Publication Publication Date Title
MX2010004772A (es) Recubrimiento mejorado de tableta.
FR2949062B1 (fr) Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
WO2008120207A3 (en) Compositions for nasal delivery
CY1111230T1 (el) Συσκευη για την παραγωγη ενος αφεψηματος αρωματικου ποτου
ZA200807767B (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
WO2011098611A3 (en) Targeted alpha- particle emitting complexes comprising thorium radionuclide hydroxypyridinone containing ligand
WO2009117130A3 (en) Extended release forumulation containing a wax
WO2007095041A3 (en) Pharmaceutical formulations
WO2009121039A3 (en) Administration of benzodiazepine compositions
WO2007117661A3 (en) Drug microparticles
UA93903C2 (ru) Производные тетрагидроизохинолина для повышения функции памяти
WO2010127205A3 (en) Fixed dose drug combination formulations
IL196426A0 (en) Microparticulates based on an amphiphilic copolymer, processes for the preparation thereof and pharmaceutical compositions containing the same
WO2011143118A3 (en) Alcohol-resistant formulations
WO2008134013A3 (en) Pharmaceutical excipient complex
MX2008002492A (es) Composiciones farmaceuticas que comprenden un farmaco dependiente del ph, un modificador del ph, y un agente retardante.
MX2010005036A (es) Formulaciones de polvo seco que comprenden derivados del acido ascorbico.
WO2008072985A3 (en) Pour on formulation
SI2151439T1 (sl) Nitrogeniran aromatski derivat s 6-členskim obročem in farmacevtsko sredstvo, ki obsega ta derivat
WO2008128191A3 (en) Oral cephalotaxine dosage forms
EP1584335A3 (en) Active substance combination comprising a carbinol composition and an opioid
WO2009120844A3 (en) Pharmaceutical compositions comprising insulin sensitizer and insulin secretagogue
WO2008041116A3 (en) Formulations of active principles incorporated in slns suitable for transdermal administration
WO2007121471A3 (en) Dialkyl ether delivery agents
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent

Legal Events

Date Code Title Description
FA Abandonment or withdrawal